Mid to Long-term Quality of Life Effects Of imatiNIb Versus DASatinib in Chronic Myeloid Leukemia Patients (LEONIDAS)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms LEONIDAS
- 23 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 23 May 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.